Shareholders SueWallSt in New Class Action Against Snap Inc. – Act Now

NEW YORK CITY, NY / ACCESS Newswire / October 6, 2025 / NEW YORK, NY / ACCESS Newswire / October 6, 2025 / – SueWallSt: Class Action Filed Against Snap Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities […]

Source Energy Services Announces TSX Approval of Amended Normal Course Issuer Bid

CALGARY, AB / ACCESS Newswire / October 6, 2025 / Source Energy Services Ltd. ("Source" or the "Company") is pleased to announce that the Toronto Stock Exchange (the "TSX") has accepted Source’s application to amend its previously approved Normal Course Issuer Bid ("NCIB") to purchase up to 1,189,458 of its outstanding common shares ("Common Shares")

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages V.F. Corporation Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – VFC

NEW YORK CITY, NY / ACCESS Newswire / October 6, 2025 / WHY: New York, N.Y., October 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE:VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the "Class Period"), of the important November 12,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. – ATYR

NEW YORK CITY, NY / ACCESS Newswire / October 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether aTyr and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celanese Corporation – CE

NEW YORK CITY, NY / ACCESS Newswire / October 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") (NYSE:CE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Celanese and certain of its officers and/or directors

Pistachio recalled due to Salmonella

Product:Pistachio Issue: Food – Microbial contamination – Salmonella Distribution: Quebec See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA) https://rt.newswire.ca/rt.gif?NewsItemId=C2625&Transmission_Id=202510061728CANADANWWEB______C2625&DateId=20251006

YORK® Rooftop Unit Passes and Exceeds Testing Phase of U.S. Department of Energy Commercial Building HVAC Technology Challenge

— YORK developed an innovative, all-electric 15-ton rooftop unit heat pump for cold climates — One of eight manufacturers as part of this testing phase, YORK passed lab validation YORK®, a premium brand part of the Bosch Home Comfort Group, has passed and exceeded the laboratory testing phase of the U.S. Department of Energy (DOE)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Roblox Corporation – RBLX

NEW YORK, NY, NY / ACCESS Newswire / October 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Roblox Corporation ("Roblox" or the "Company") (NYSE:RBLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Roblox and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

NEW YORK, NY, NY / ACCESS Newswire / October 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ:AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Agios and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. – SLNO

NEW YORK, NY, NY / ACCESS Newswire / October 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or

Scroll to Top